Lupin Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LUPIN PHARMS
LUPIN PHARMS has eleven approved drugs.
There are two tentative approvals on LUPIN PHARMS drugs.
Summary for Lupin Pharms
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 11 |
Drugs and US Patents for Lupin Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Pharms | SUPRAX | cefixime | FOR SUSPENSION;ORAL | 065129-001 | Feb 23, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Lupin Pharms | DICLOFENAC SODIUM | diclofenac sodium | SOLUTION;TOPICAL | 208021-001 | Sep 20, 2022 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lupin Pharms | NORGESTIMATE AND ETHINYL ESTRADIOL | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 200541-001 | Jun 25, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LUPIN PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Oral Suspension | 500 mg/5 mL | ➤ Subscribe | 2014-07-22 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
